STREAMLINE HEALTH SOLUTIONS INC. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q1 FY2026 As of Apr 30, 2025	Q4 FY2025 As of Jan 31, 2025	Q3 FY2025 As of Oct 31, 2024	Q2 FY2025 As of Jul 31, 2024	Q1 FY2025 As of Apr 30, 2024	Q4 FY2024 As of Jan 31, 2024	Q3 FY2024 As of Oct 31, 2023	Q2 FY2024 As of Jul 31, 2023	Q1 FY2024 As of Apr 30, 2023	Q4 FY2023 As of Jan 31, 2023	Q3 FY2023 As of Oct 31, 2022	Q2 FY2023 As of Jul 31, 2022	Q1 FY2023 As of Apr 30, 2022	Q4 FY2022 As of Jan 31, 2022	Q3 FY2022 As of Oct 31, 2021	Q2 FY2022 As of Jul 31, 2021	Q1 FY2022 As of Apr 30, 2021	Q4 FY2021 As of Jan 31, 2021	Q3 FY2021 As of Oct 31, 2020	Q2 FY2021 As of Jul 31, 2020
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowance for credit losses of $59,000 and $59,000, respectively
Contract receivables
Assets held in escrow
Prepaid and other current assets
Current assets of discontinued operations
Total current assets

Non-current assets:
Property and equipment, net of accumulated amortization of $144,000 and $110,000 respectively
Right-of use asset for operating lease
Capitalized software development costs, net of accumulated amortization of $7,107,000 and $6,224,000, respectively
Capitalized software development costs, net of accumulated amortization of $7,092,000 and $6,762,000, respectively
Intangible assets, net of accumulated amortization of $6,064,000 and $5,655,000, respectively
Goodwill
Other
Long-term assets of discontinued operations
Total non-current assets
Total assets

Current liabilities:
Accounts payable
Accrued expenses
Accrued income taxes
Current portion of term loan
Royalty liability
Operating lease obligations
Current liabilities of discontinued operations
Term loan, net of deferred financing costs
Line of credit
Notes payable, net of deferred financing costs
Deferred revenues
Acquisition earnout liability
Total current liabilities

Non-current liabilities:
Term loan, net of deferred financing costs
Line of credit, net of current portion
Lease obligations, less current portion
Operating lease obligations, less current portion
Acquisition earnout liability, less current portion
Other non-current liabilities
Non-current portion of notes payable
Notes payable, net of deferred financing costs
Deferred revenues, less current portion
Total non-current liabilities
Total liabilities

Stockholders’ equity:
Common stock, $0.01 par value per share, 85,000,000 shares authorized; 4,324,091 and 4,264,482 shares issued and outstanding, respectively
Additional paid in capital
Accumulated deficit
Net loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments